Free tool
FAERS Monitor: Mucinex
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021282 or its brand name (Mucinex, Guaifenesin). Reports on generic versions are filed under their own applications.
Reports
29,629
Serious
14,639
49% of reports
Hospitalization
7,657
Death reported
2,164
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective2,481
- dyspnoea2,219
- fatigue1,810
- nausea1,771
- diarrhoea1,677
- pneumonia1,671
- cough1,601
- headache1,535
- dizziness1,415
- pain1,260
- off label use993
- vomiting953
- death930
- asthenia924
- fall894
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 164 |
| 2005 | 231 |
| 2006 | 291 |
| 2007 | 277 |
| 2008 | 336 |
| 2009 | 400 |
| 2010 | 683 |
| 2011 | 681 |
| 2012 | 826 |
| 2013 | 765 |
| 2014 | 912 |
| 2015 | 2,136 |
| 2016 | 3,169 |
| 2017 | 2,376 |
| 2018 | 2,134 |
| 2019 | 2,119 |
| 2020 | 2,281 |
| 2021 | 1,420 |
| 2022 | 1,700 |
| 2023 | 1,801 |
| 2024 | 1,863 |
| 2025 | 2,159 |
| 2026 | 902 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,024,530 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| coughSignal | 1,601 | 4.1 | 3.9 | 3,733 |
| pneumoniaSignal | 1,671 | 3.7 | 3.5 | 3,289 |
| dyspnoeaSignal | 2,219 | 2.8 | 2.7 | 2,606 |
| dizzinessSignal | 1,415 | 2.0 | 1.9 | 740 |
| fall | 894 | 1.9 | 1.8 | 391 |
| diarrhoea | 1,677 | 1.8 | 1.8 | 669 |
| asthenia | 924 | 1.7 | 1.6 | 299 |
| headache | 1,535 | 1.7 | 1.7 | 496 |
| fatigue | 1,810 | 1.7 | 1.6 | 482 |
| nausea | 1,771 | 1.6 | 1.5 | 401 |
| pain | 1,260 | 1.5 | 1.4 | 185 |
| vomiting | 953 | 1.4 | 1.4 | 130 |
| drug ineffective | 2,481 | 1.3 | 1.3 | 224 |
| off label use | 993 | 0.8 | 0.8 | 49 |
| death | 930 | 0.8 | 0.7 | 69 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.